US regulators are reportedly nearing approval for the proposed merger between Paramount and Warner Bros. Discovery. This potential deal could significantly reshape the media landscape.

U.S. regulators are reportedly investigating or considering regulations for prediction market platforms such as Kalshi and Polymarket, citing concerns over individuals profiting from privileged information.

Novo Nordisk's weight-loss drug, Wegovy, has received approval from U.S. regulators for a higher dose. This development expands the treatment options available for weight management.

Bayer has been granted priority review by U.S. regulators for the label expansion of its drug Kerendia, indicating a potential broadening of its approved uses.

U.S. regulators have put forward proposals for a significant overhaul of anti-money-laundering rules, aiming to strengthen financial crime prevention.

AstraZeneca has secured approval from U.S. regulators for its new hypertension drug, expanding its pharmaceutical portfolio.

Coinbase has announced it has secured conditional approval from U.S. regulators for a trust charter, a significant step for the cryptocurrency exchange.